SecBot SecBot

340B PATIENTS Act of 2025

H.R. 4581 Rep. Doris Matsui (D-CA-7) In committee
Bill text PDF
  1. Introduced Jul 22
  2. Committee Jul 22
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 22, 2025Next: House vote
463d ago Jul 22, 2025: Referred to the House Committee on Energy and Commerce.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 3 filings
Subscribe to see spend
Member trades
8trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 2
Search all 2 companies, their asks and price moves Subscribe

Summary

This bill clarifies and strengthens the 340B drug discount program by requiring drug manufacturers to offer discounted prices to covered entities regardless of how or where the drug is dispensed, and by prohibiting manufacturers from placing certain conditions on those purchases. It also establishes new penalties for violations and allows covered entities to assert claims of violations.

Summary of the bill text as introduced in House (Jul 22, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.